Matarin Capital Management, LLC - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 132 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Matarin Capital Management, LLC ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$1,787,631,000
-7.7%
174,403
+17.6%
0.20%
-25.1%
Q2 2016$1,937,125,000
+2.2%
148,325
-13.9%
0.26%
-0.8%
Q1 2016$1,895,322,000
+18.5%
172,302
-0.9%
0.26%
+10.9%
Q4 2015$1,599,871,000
-16.0%
173,899
-36.6%
0.24%
-38.7%
Q3 2015$1,903,580,000274,2910.39%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Athos Capital Ltd 410,389$4,596,0003.46%
GLG Partners LP 2,586,437$28,968,0001.54%
Nine Chapters Capital Management LLC 32,300$362,0000.80%
FNY Partners Fund LP 335,900$3,762,0000.64%
MENTA CAPITAL LLC 373,523$4,183,0000.61%
Yakira Capital Management, Inc. 85,500$958,0000.32%
Sapphire Star Partners LP 18,724$209,0000.27%
GAM Holding AG 541,025$6,059,0000.26%
Bowling Portfolio Management LLC 127,873$1,432,0000.22%
Kassirer Asset Management Corp 15,000$168,0000.16%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders